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INTRODUCTION:  In  recent  years,  cytoreductive  surgery  (CRS)  with  hyperthermic  intraperitoneal
chemotherapy  (HIPEC)  has  gained  increasing  acceptance  as a treatment  modality  for  peritoneal
carcinomatosis.  In female  patients,  this  procedure  involves  a  total  hysterectomy  and  bilateral  saphingo-
oophorectomy  to remove  the  pelvic  peritoneum.  We  present  a case  of an  unfortunate  female  adolescent
with  peritoneal  carcinomatosis  who  underwent  cytoreductive  surgery  and  HIPEC. In view of the  com-
pelling  circumstance,  an  innovative  surgical  technique  was  used  to attempt  ovarian  preservation.
PRESENTATION OF  CASE:  A 14  year  old girl  with  carcinoma  of the  sigmoid  colon  and  peritoneal  metas-
tases  was  offered  cytoreductive  surgery  and  hyperthermic  intra-peritoneal  chemotherapy.  In  view  of  her
age,  ovarian  preservation  with  subcutaneous  transposition  was  performed  during  cytoreductive  surgery.
She  is  currently  well  6 months  post  surgery  and  has  resumed  normal  menstruation.  We  review  the
literature  regarding  ovarian  preservation  with  subcutaneous  transposition  and discuss  its  beneﬁt  in pre-
menopausal  women  undergoing  peritonectomy  and cytoreductive  surgery  for  peritoneal  carcinomatosis.
DISCUSSION:  Subcutaneous  transposition  of  the ovary  in  pre-menopasual  patients  requiring  cytoreductive
surgery  spares  them  the  sequelae  of  surgical  castration.  The  subcutaneous  location  of  the  transposed
ovary  conveys  advantages  such  as the  ease  of  ultrasound  surveillance  and  removal  in event  of  disease
recurrence.  It also  retains  the  possibility  of  future  conception  as  the  transposed  ovary  can  easily  be
accessed  for  ovum  extraction  with  assisted  reproductive  techniques.
CONCLUSION: Ovarian  preservation  with  subcutaneous  transposition  is a technique  worth  considering
in  the  treatment  of pre-menopausal  women  who  require  cytoreductive  surgery  for  peritoneal  carcino-
matosis.
gical © 2013 Sur
. Introduction
Peritoneal carcinomatosis is an indicator of advanced tumor
tage, disease progression or recurrence in malignancies of gas-
rointestinal origin. Regardless of primary tumor site, prognosis is
niformly poor. This is particularly so for tumors of gastrointesti-
al origin whereby median survival approximates six months. The
onventional treatment of choice for patients with peritoneal car-
inomatosis is palliative systemic chemotherapy. Surgery is usually
eserved for selected patients and mainly for the purpose of symp-
om palliation. However, in recent years, cytoreductive surgery
CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)
as gained increasing acceptance as a treatment modality for
elected patients with peritoneal carcinomatosis.1–4 CRS consists
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of several surgical procedures depending on the site of manifesta-
tion of peritoneal carcinomatosis. Surgery may  include parietal and
visceral peritonectomy, greater omentectomy, splenectomy, chole-
cystectomy, stripping of the liver capsule and bowel resection if
gross disease is present on bowel surfaces. In female patients, this
procedure invariably involves a total hysterectomy and bilateral
saphingo-oophorectomy as the pelvic peritoneum is often involved
by disease. Adequate cytoreduction thus entails removal of the
female reproductive organs and the ovaries. We  present a case
of an unfortunate adolescent with peritoneal carcinomatosis who
underwent cytoreductive surgery and HIPEC. In view of the com-
pelling circumstance, we  adopted an innovative surgical technique
to attempt ovarian preservation in this young patient.
Open access under CC BY-NC-ND license.2.  Presentation of case
A 14 year old girl presented in June 2011 with abdominal pain
and irregular bowel habits of 4 months duration. She underwent a
NC-ND license.
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olonoscopy and was diagnosed with adenocarcinoma of the sig-
oid colon which she underwent laparoscopic anterior resection
n 6/7/2011. Intra-operatively, several 2–3 mm nodules were seen
n the peritoneal cavity which were left in situ (Fig. 1). The resected
pecimen’s histology was poorly differentiated adenocarcinoma of
ignet ring cell type with local invasion beyond the muscularis pro-
ria, 3 out of 4 lymph nodes were positive with no lymphovascular
r perineural invasion. Resection margins were clear.
In view of peritoneal involvement, the patient was treated for
etastatic disease and underwent palliative chemotherapy (FOL-
OX and ERBITUX) from 8/8/11 to 19/9/11. Positron Emission
omography (PET) scan performed post chemotherapy showed
o evidence of any disease. During the course of treatment, the
atient’s family did extensive research on her condition and came
cross the option of cytoreductive surgery. However, this was
navailable in the institution she was currently receiving treat-
ent. Care was thus transferred to our tertiary institution for
ytoreductive surgery (CRS).
Diagnostic laparoscopy performed on 4/10/11 showed nodules
n the uterus and broad ligament with no other distant metas-
asis. Biopsies of the nodules revealed no malignancy. The case
as discussed at the multi-disciplinary tumor board and decision
as made to recommend peritonectomy and hyperthermic intra-
eritoneal chemotherapy (HIPEC). The patient and family were
ounseled on the possibility of a total hysterectomy and bilateral
alphingo-oophorectomy during CRS and consented for the proce-
ure.
Patient underwent peritonectomy, bilateral salpingectomy,
ubcutaneous transposition of bilateral ovaries and HIPEC on
1/10/11. Intra-operatively, multiple nodules were found along the
elvic peritoneum but these had reduced in size after adjuvant
hemotherapy. Frozen section from the pelvic nodules were posi-
ive for malignancy. Peritoneal nodules were also found involving
he fallopian tubes but sparing the ovaries. Peritoneal carcinomato-
is index was 3.
In view of the patient’s age, the disease free ovaries were pre-
erved with its supplying gonadal vessels and transposed into the
nterior abdominal wall subcutaneously (Figs. 2 and 3). Ovarian
iopsies were not performed prior to the procedure.
Postoperative progress was uneventful. The patient tolerated
iet on the 7th post operative day and received 2 cycles of intra-
eritoneal chemotherapy. She was discharged well on the 13th
ost-operative day and has resumed her normal menses.
The patient represented with intestinal obstruction 2 months
fter discharge and laparotomy revealed intestinal obstruction
Fig. 1. Peritoneal nodules present during laparoscopic anterior resection.Fig. 2. Ovary preserved and hitched onto the subcutaneous layer.
secondary to adhesion bands. 2 small pelvic nodules were also
noted at the sigmoid mesentery. Adhesiolysis was performed
and the peritoneal nodules were biopsied. The patient’s intesti-
nal obstruction resolved after adhesiolysis but histology from the
pelvic nodules revealed metastatic adenocarcinoma. She is cur-
rently undergoing further palliative chemotherapy and was  well
on clinic review 6 months after the CRS was  performed.
3. Discussion
In recent years, cytoreductive surgery and hyperthermic intra
peritoneal chemotherapy has gained acceptance as a treatment
modality for selected patients with peritoneal carcinomatosis.1–4
CRS in pre-menopausal women  involves ovariectomy and patients
suffer sequelae like climacteric symptoms, osteoporosis and an
increased risk of cardiovascular disease. These patients may  beneﬁt
from ovarian preservation if disease clearance is not compromised.
We  present the only case report to our knowledge that describes
ovarian preservation in the setting of CRS.
The surgical procedure performed for this patient was as
follows. Following division of the utero-ovarian ligament, the
infundibular pelvic ligament was carefully dissected free, taking
care to avoid injury to the ureter and ovarian vessels. The pedi-
cle of the ovarian vessels on each side was isolated and dissected
free of the peritoneal attachments. The subcutaneous site of ovar-
ian transposition was  identiﬁed and an incision made over the skin
and fascia. Each ovary was  then gently pulled through the incision
Fig. 3. Picture after preservation and subcutaneous transposition of bilateral
ovaries.
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nd tagged to the fascia using absorbable vicryl stitches before skin
losure.
Subcutaneous transposition of the ovary in this young patient
pares her the sequelae of surgical castration and conveys other
dvantages. The subcutaneous location of the transposed ovary
s amenable to ultrasound surveillance for any subsequent ovar-
an pathology. In the event of disease recurrence in the ovary,
ts subcutaneous location ensures easy removal of the transposed
vary without having to breach the peritoneal cavity. It also retains
he theoretical possibility of conception in future as the trans-
osed ovary can easily be accessed for ovum extraction if assisted
eproductive techniques are desired in future although this would
equire a surrogate pregnancy.
Ovarian exteriorization was ﬁrst described by Kovacev in the
etting of carcinoma of the cervix.5 A major drawback of this
echnique was the risk of intestinal herniation and post operative
dhesions, an unfortunate complication encountered by our patient
n the case vignette. Fujiwara et al. has proposed a modiﬁcation of
his method by using the retro-peritoneal space as the route to
pproach the abdominal subcutaneous fat.6 This may  help mini-
ize the risk of intestinal herniation or post-operative adhesions.
he method has been successfully utilized in 27 patients with no
ajor complications of intestinal obstruction reported and may  be
he preferred option if ovarian preservation was to be attempted.
There have been few publications reporting the long term ovar-
an function after subcutaneous transposition of the ovary. The
ame institution which pioneered the retroperitoneal approach for
ubcutaneous ovarian transposition reported that although ovar-
an function declined post subcutaneous transposition, transposed
varies in postmenopausal women still secrete estrogen equivalent
o that provided by hormone replacement therapy.7 In contrast,
uo et al. reported normal short-term and long-term endocrine
unction post subcutaneous ovarian transposition.8 Although data
egarding this uncommon surgical procedure remains limited, the
vailable literature seems to suggest that it at least results in hor-
onal levels comparable to that provided by hormone replacement
herapy.
The question of whether reproductive potential is preserved
ost subcutaneous ovarian transposition remains unanswered.
here have been no case reports to our knowledge which describes
uccessful conception post subcutaneous ovarian transposition. In
he current era of reproductive medicine, other viable alternatives
or this patient include cryopreservation of oocytes and ovarian
issue. These should ideally be performed prior to the initiation
f chemotherapy to optimize the quality of oocytes retrieved.9,10
ocyte cryopreservation may  be performed for both mature and
mmature oocytes. In the latter scenario, the immature oocytes are
equired to undergo in vitro maturation either prior to freezing
r after thawing.11 Another alternative for fertility preservation
s ovarian tissue cryopreservation with future implantation. Sim-
lar to subcutaneous ovarian transposition, this technique has the
dded advantage of preservation of ovarian hormonal function and
pares pre-menopausal women the adverse effects of ovarian cas-
ration. This technique has led to 13 successful live births in a
ecently published case series.12 From a theoretical view point, fer-
ility results from subcutaneous ovarian transposition should be
uperior to that of transplantation of cryopreserved ovarian tis-
ue. It preserves the endogenous vascular supply of the ovary and
inimizes damage to the ovarian tissue during freezing and thaw-
ng which has been shown in animal studies to cause signiﬁcant
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loss in follicles due to ischemic damage.13 Thus, while evidence
supporting subcutaneous ovarian transposition remains limited, it
is a technique worth considering in the treatment of young pre-
menopausal women  requiring peritonectomy and cytoreductive
surgery for peritoneal malignancy.
4. Conclusion
Ovarian preservation with subcutaneous transposition is a tech-
nique worth considering in the treatment of pre-menopausal
women who  require cytoreductive surgery for peritoneal carcino-
matosis.
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